Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir versus continued HAART: the Trizal study (Q44309078)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir versus continued HAART: the Trizal study
scientific article

    Statements

    Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir versus continued HAART: the Trizal study (English)
    0 references
    Alain Lafeuillade
    Nathan Clumeck
    Josep Mallolas
    Hans Jaeger
    Jean-Michel Livrozet
    Maria do Sameira Ferreira
    Margaret Johnson
    Arnaud Cheret
    Zeina Antoun
    European Trizal team
    1 January 2003

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit